References
- Jefferson JA, Nelson PJ, Najafian B, Shankland SJ. Podocyte disorders: core curriculum 2011. Am J Kidney Dis 2011;58:666–77
- Brinkkoetter PT, Ising C, Benzing T. The role of the podocyte in albumin filtration. Nat Rev Nephrol 2013;9:328–36
- Kriz W, Shirato I, Nagata M, et al. The podocyte's response to stress: the enigma of foot process effacement. Am J Physiol Renal Physiol 2013;304:F333–47
- George B, Holzman LB. Signaling from the podocyte intercellular junction to the actin cytoskeleton. Semin Nephrol 2012;32:307–18
- Matsusaka T, Sandgren E, Shintani A, et al. Podocyte injury damages other podocytes. J Am Soc Nephrol 2011;22:1275–85
- Drozdova T, Papillon J, Cybulsky AV. Nephrin missense mutations: induction of endoplasmic reticulum stress and cell surface rescue by reduction in chaperone interactions. Physiol Rep 2013;1:e00086
- Machado JR, Rocha LP, Neves PD, et al. An overview of molecular mechanism of nephrotic syndrome. Int J Nephrol 2012;2012:937623
- Volker LA, Schurek EM, Rinschen MM, et al. Characterization of a short isoform of the kidney protein podocin in human kidney. BMC Nephrol 2013;14:102
- Godel M, Ostendorf BN, Baumer J, et al. A novel domain regulating degradation of the glomerular slit diaphragm protein podocin in cell culture systems. PLoS One 2013;8:e57078
- Song B, Smink AM, Jones CV, et al. The directed differentiation of human iPS cells into kidney podocytes. PLoS One 2012;7:e46453
- Brophy TM, Coller BS, Ahamed J. Identification of the thiol isomerase-binding peptide, mastoparan, as a novel inhibitor of shear-induced transforming growth factor beta1 (TGF-beta1) activation. J Biol Chem 2013;288:10628–39
- Xu HL, Ou C, Rong L, Zhou TB. The potential signal pathway between PAX2 and CD2AP in the renal interstitial fibrosis disease. J Recept Signal Transduct Res 2014 (epub ahead of print)
- Yang W, Wang J, Shi L, et al. Podocyte injury and overexpression of vascular endothelial growth factor and transforming growth factor-beta 1 in adriamycin-induced nephropathy in rats. Cytokine 2012;59:370–6
- Herman-Edelstein M, Weinstein T, Gafter U. TGFbeta1-dependent podocyte dysfunction. Curr Opin Nephrol Hypertens 2013;22:93–9
- Herman-Edelstein M, Thomas MC, Thallas-Bonke V, et al. Dedifferentiation of immortalized human podocytes in response to transforming growth factor-beta: a model for diabetic podocytopathy. Diabetes 2011;60:1779–88
- Bengtsson AM, Jonsson G, Magnusson C, et al. The cysteinyl leukotriene 2 receptor contributes to all-trans retinoic acid-induced differentiation of colon cancer cells. BMC Cancer 2013;13:336
- Zhou TB, Drummen GP, Qin YH. The controversial role of retinoic acid in fibrotic diseases: analysis of involved signaling pathways. Int J Mol Sci 2012;14:226–43
- Khurana S, Bruggeman LA, Kao HY. Nuclear hormone receptors in podocytes. Cell Biosci 2012;2:33
- Sato Y, Ramalanjaona N, Huet T, et al. The “Phantom Effect” of the Rexinoid LG100754: structural and functional insights. PLoS One 2010;5:e15119
- Das BC, Thapa P, Karki R, et al. Retinoic acid signaling pathways in development and diseases. Bioorg Med Chem 2014;22:673–83
- Vaughan MR, Pippin JW, Griffin SV, et al. ATRA induces podocyte differentiation and alters nephrin and podocin expression in vitro and in vivo. Kidney Int 2005;68:133–44
- He JC, Lu TC, Fleet M, et al. Retinoic acid inhibits HIV-1-induced podocyte proliferation through the cAMP pathway. J Am Soc Nephrol 2007;18:93–102
- Zhong Y, Wu Y, Liu R, et al. Novel retinoic acid receptor alpha agonists for treatment of kidney disease. PLoS One 2011;6:e27945
- Dos Santos GA, Kats L, Pandolfi PP. Synergy against PML-RARa: targeting transcription, proteolysis, differentiation, and self-renewal in acute promyelocytic leukemia. J Exp Med 2013;210:2793–802
- Hu XX, Zhong L, Zhang X, et al. NLS-RARalpha promotes proliferation and inhibits differentiation in HL-60 cells. Int J Med Sci 2014;11:247–54
- Bi Y, Gong M, He Y, et al. Adenovirus-mediated RAR-beta over-expression enhances ATRA-induced neuronal differentiation of rat mesenchymal stem cells. Arch Med Sci 2013;9:314–22
- Papeta N, Zheng Z, Schon EA, et al. Prkdc participates in mitochondrial genome maintenance and prevents adriamycin-induced nephropathy in mice. J Clin Invest 2010;120:4055–64
- Zhou TB, Qin YH, Lei FY, et al. Prohibitin attenuates oxidative stress and extracellular matrix accumulation in renal interstitial fibrosis disease. PLoS One 2013;8:e77187
- Zhou TB, Qin YH, Lei FY, et al. All-trans retinoic acid regulates the expression of apolipoprotein E in rats with glomerulosclerosis induced by adriamycin. Exp Mol Pathol 2011;90:287–94
- Liu HF, Guo LQ, Huang YY, et al. Thiazolidinedione attenuate proteinuria and glomerulosclerosis in adriamycin-induced nephropathy rats via slit diaphragm protection. Nephrology (Carlton) 2010;15:75–83
- Wang Z, Liu J, Sun W. Effects of asiaticoside on levels of podocyte cytoskeletal proteins and renal slit diaphragm proteins in adriamycin-induced rat nephropathy. Life Sci 2013;93:352–8
- Hu P, Qin YH, Pei J, et al. Beneficial effect of all-trans retinoic acid (ATRA) on glomerulosclerosis rats via the down-regulation of the expression of alpha-smooth muscle actin: a comparative study between ATRA and benazepril. Exp Mol Pathol 2010;89:51–7
- Chen CA, Hwang JC, Guh JY, et al. TGF-beta1 and integrin synergistically facilitate the differentiation of rat podocytes by increasing alpha-smooth muscle actin expression. Transl Res 2006;148:134–41
- Qin YH, Lei FY, Hu P, et al. Effect of all-trans retinoic acid on renal expressions of matrix metalloproteinase-2, matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in rats with glomerulosclerosis. Pediatr Nephrol 2009;24:1477–86
- Ratnam KK, Feng X, Chuang PY, et al. Role of the retinoic acid receptor-alpha in HIV-associated nephropathy. Kidney Int 2011;79:624–34